Laboratorios ERN collaborates with the Master’s in Logistics and Supply Chain Management at the University of Barcelona

Laboratorios ERN collaborates with the Master’s in Logistics and Supply Chain Management at the University of Barcelona
The collaboration with the Institut de Formació Contínua–IL3 allows students to apply their knowledge to a real case in the pharmaceutical sector.
Laboratorios ERN has strengthened its ties with the academic field through a collaboration with the Master’s in Logistics and Supply Chain Management at the Institut de Formació Contínua–IL3, part of the University of Barcelona. This initiative has provided students with the opportunity to work with real data from the pharmaceutical environment to develop their Master’s Thesis (TFM).
Within this collaboration framework, several master’s students have conducted an applied study for the implementation and expansion of a warehouse in a pharmaceutical company, using as a basis the data and experience provided by Laboratorios ERN. This project has represented a technical and strategic challenge for the students, who have been able to apply their knowledge in a real, highly demanding environment.

Laboratorios ERN congratulates the recently graduated students for the excellent work they have accomplished. This initiative reinforces the laboratory’s commitment to education, knowledge transfer, and the connection between the business sector and the academic world.
Laboratorios ERN will continue to promote this type of collaboration, aligned with its vision of social responsibility and its commitment to continuous innovation across all areas of its activity.
noticias relacionadas
Laboratorios ERN signs a collaboration agreement with Lupin Limited and launches a new medicine in Spain for the treatment of asthma and COPD
With more than 80 years of history, the laboratory founded in Barcelona continues to advance its sustainable growth strategy through alliances with leading international partners. Laboratorios ERN is taking a decisive step in strengthening its respiratory portfolio with the launch in Spain of Luforbec® (beclometasone / formoterol), 100/6, a fixed-dose combination in a pressurised metered-dose […]
Laboratorios ERN and Ercros, beneficiaries of CDTI funding for the development of the ANTISALINA project
Laboratorios ERN and Ercros are beneficiaries of public funding awarded under the National Cooperative R&D Programme of the Centre for the Development of Technology and Innovation (CDTI). Thanks to this funding, both companies are jointly advancing the ANTISALINA project, aimed at developing new innovative solutions in the field of research and experimental development. At Laboratorios […]
Launch of Intravenous Fosfomycin Commercialization in the United States
The commercialization of intravenous fosfomycin has begun in the United States. This hospital-use antibiotic is a key treatment for complicated urinary tract infections and is being introduced through a strategic agreement between LABORATORIOS ERN and the pharmaceutical company Meitheal Pharmaceuticals, a specialist in the commercialization of generic and biologic injectable products. Intravenous fosfomycin was approved […]
Laboratorios ERN joins the Fundación Empresa y Clima (FEC) as a Silver member
We are proud to announce that Laboratorios ERN has officially joined the Fundación Empresa y Clima (FEC) as a Silver member, reinforcing our commitment to climate action and global sustainability. This alliance allows us to become part of a business community committed to the transition toward a low-carbon economy, alongside other companies that share the […]
ERN Laboratories supports research into pediatric rare diseases at Sant Joan de Déu Hospital in Barcelona.
During 2026, ERN Laboratories will allocate €1 for each unit sold of Astenolit Infantil, a nutritional supplement designed to support children’s energy levels and immune defenses, to benefit pediatric rare disease research at Sant Joan de Déu. This initiative is part of ERN Laboratories’ longstanding commitment to pediatrics and child health, supporting projects that contribute […]